An Examination of the Effect of Registration Errors on FDG-PET Evaluation of Chemotherapy Response in Sarcoma

被引:0
|
作者
Wolsztynski, E. [1 ]
O'Sullivan, F. [1 ]
Roy, S. [1 ]
O'Sullivan, J. [1 ]
Eary, J. F. [2 ]
机构
[1] Univ Coll Cork, Sch Math Sci, Dept Stat, Western Gateway Bldg,Coll Rd, Cork, Ireland
[2] Univ Washington, Dept Radiol, Seattle, WA 98195 USA
关键词
D O I
暂无
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
Statistical quantitators that summarise standardized uptake value (SUV) distributions are widely used measures of metabolic activity in the analysis of static Positron Emission Tomography (PET) data. Amongst them, SUV mean and total lesion glycolysis (TLG) have been shown to yield a strong prognostic value for many diseases, which contributed to the rapid expansion of PET-based assessment of diagnosis, prognosis and treatment monitoring methodologies. Such measures, however, remain utilized in a point-wise fashion, that is, without a complementary assessment of their accuracy. Without such information, it is not clear that the assessment would be reliable. This raises important questions in particular for prognosis and therapeutic assessment. We consider here a statistical method that was recently proposed for the monitoring of neoadjuvant chemotherapy for sarcoma. This approach consists in pairing pre- and post-therapy scans in order to quantify the response to therapy, in terms of change in mean tracer uptake, along with an associated estimated accuracy. Pairing the uptake information requires co-registering the two sets of images, which most likely introduces a mis-registration error in the analytic framework. We propose to examine the effect of this mis-registration in a quantified analysis where we formulate the problem as a comparison with a classical (unpaired) therapeutic assessment. We demonstrate that mis-registration should not prevent paired-based methodologies. In particular, the derived measure of assessment accuracy remains more powerful even for large typical mis-registration scales. The viability of this method and its effect on prognostic utility are further considered via multivariate Cox survival analyses on a clinical dataset of 50 sarcoma studies with extensive follow-up information. Encouraging results suggest this approach could generalize to the analysis of other diseases and imaging modalities.
引用
收藏
页码:2876 / 2880
页数:5
相关论文
共 50 条
  • [22] Early response evaluation by FDG-PET predicts histopathological response in adenocarcinomas of the esophagogastric junction after neoadjuvant chemotherapy
    Herrmann, K.
    Ott, K.
    Wieder, H.
    Becker, K.
    Busch, R.
    Siewert, J.
    Weber, W.
    Schwaiger, M.
    Krause, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S165 - S165
  • [23] Volumetric FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in paediatric patients with Ewing sarcoma and osteosarcoma
    Bailly, C.
    Campion, L.
    Thebaud, E.
    Corradini, N.
    Moreau, A.
    Dansette, D.
    Bodere, F. Kraeber
    Carlier, T.
    Milin, C. Bodet
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S257 - S257
  • [24] Effect of dental implants on tracer distribution in FDG-PET and FDG-PET/CT
    Beyer, T
    Müller, SP
    Terschüren, B
    Stergar, H
    Kuehl, H
    Bockisch, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 : S409 - S409
  • [25] Evaluation of Early Response to Neoadjuvant Chemotherapy with FDG PET/CT and MRI in Pediatric Patients with Bone Sarcoma
    Caglar, M.
    Aydin, B.
    Ergen, B.
    Karabulut, E.
    Akyuz, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S205 - S206
  • [26] FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients
    Soubra, Ayman
    Gencturk, Mehmet
    Froelich, Jerry
    Balaji, Priya
    Gupta, Shilpa
    Jha, Gautam
    Konety, Badrinath R.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (05) : 360 - 364
  • [27] FDG-PET in the evaluation of cervical cancer
    Macapinlac, HA
    GYNECOLOGIC ONCOLOGY, 2005, 99 (03) : S171 - S172
  • [28] Correlation of Dual Time Point FDG-PET with Response to Chemotherapy in Multiple Myeloma
    Taghvaei, Raheleh
    Oestergaard, Brian
    Zadeh, Mahdi Zirakchian
    Raynor, William
    Paydary, Koosha
    Acosta-Montenegro, Oswaldo
    Nielsen, Anne
    Werner, Thomas
    Abildgaard, Niels
    Hoilund-Carlsen, Poul Flemming
    Alavi, Abass
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58
  • [29] The role of FDG-PET in the early detection of response of colorectal liver metastases to chemotherapy
    Couper, GW
    Wallis, F
    Welch, A
    Sharp, PF
    Park, KGM
    Cassidy, J
    GUT, 2002, 50 : A107 - A107
  • [30] FDG-PET evaluation of vaginal carcinoma
    Lamoreaux, WT
    Grigsby, PW
    Dehdashti, F
    Zoberi, I
    Powell, MA
    Gibb, RK
    Rader, JS
    Mutch, DG
    Siegel, BA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (03): : 733 - 737